Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Assurant (AIZ) Beats Q1 Earnings and Revenue Estimates
Assurant (AIZ) Beats Q1 Earnings and Revenue Estimates

Assurant (AIZ) came out with quarterly earnings of $3.39 per share, beating the Zacks Consensus Estimate of $2.84 per share. This compares to earnings of $4.78 per share a year ago. These figures

Allegiant Travel (ALGT) Tops Q1 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Retail store, neutral atmosphere, photo by Joe Cornish: https://img.theapi.app/temp/5574eb69-dc38-42f3-aadd-6163ac8bd4a8.png
Allegiant Travel (ALGT) Tops Q1 Earnings and Revenue Estimates

Allegiant Travel (ALGT) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $0.57 per share a year ago. These

Can Netflix Run Continue Despite Tariff Threat?
Can Netflix Run Continue Despite Tariff Threat?

The latest tariff news over the weekend had to do with the movie industry. President Trump authorized the Department of Commerce and the USTR to immediately begin the process of instituting 100%

Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Lags Revenue Estimates
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Lags Revenue Estimates

Lyra Therapeutics, Inc. (LYRA) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.35 per share a year ago. These

Arista Networks (ANET) Q1 Earnings and Revenues Beat Estimates
Arista Networks (ANET) Q1 Earnings and Revenues Beat Estimates

Arista Networks (ANET) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.50 per share a year ago. These

Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag EstimatesPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates

Jazz Pharmaceuticals (JAZZ) came out with quarterly earnings of $1.68 per share, missing the Zacks Consensus Estimate of $4.51 per share. This compares to earnings of $2.68 per share a year ago

Super Micro Computer (SMCI) Q3 Earnings and Revenues Top Estimates
Super Micro Computer (SMCI) Q3 Earnings and Revenues Top Estimates

Super Micro Computer (SMCI) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.30 per share. This compares to earnings of $0.67 per share a year ago

WW International (WW) Reports Q1 Loss, Lags Revenue Estimates
WW International (WW) Reports Q1 Loss, Lags Revenue Estimates

WW International (WW) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.06 per share a year ago. These figures are

Gen Digital (GEN) Q4 Earnings and Revenues Beat Estimates
Gen Digital (GEN) Q4 Earnings and Revenues Beat Estimates

Gen Digital (GEN) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.53 per share a year ago. These figures

Redfin (RDFN) Reports Q1 Loss, Tops Revenue Estimates
Redfin (RDFN) Reports Q1 Loss, Tops Revenue Estimates

Redfin (RDFN) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to loss of $0.57 per share a year ago. These figures are

Revolve Group (RVLV) Q1 Earnings and Revenues Top Estimates
Revolve Group (RVLV) Q1 Earnings and Revenues Top Estimates

Revolve Group (RVLV) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.15 per share a year ago. These

Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates

Standard BioTools (LAB) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.23 per share a year ago. These figures are adjusted

Devon Energy (DVN) Lags Q1 Earnings Estimates
Devon Energy (DVN) Lags Q1 Earnings Estimates

Devon Energy (DVN) came out with quarterly earnings of $1.21 per share, missing the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.16 per share a year ago. These

Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates
Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates

Dynavax Technologies (DVAX) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of $0.03. This compares to loss of $0.07 per share a year ago. These figures are

Wynn Resorts (WYNN) Lags Q1 Earnings and Revenue Estimates
Wynn Resorts (WYNN) Lags Q1 Earnings and Revenue Estimates

Wynn Resorts (WYNN) came out with quarterly earnings of $1.07 per share, missing the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $1.59 per share a year ago. These

WideOpenWest (WOW) Reports Q1 Loss, Tops Revenue Estimates
WideOpenWest (WOW) Reports Q1 Loss, Tops Revenue Estimates

WideOpenWest (WOW) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.18 per share a year ago. These figures are

Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates
Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates

Voyager Therapeutics (VYGR) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.20 per share a year ago. These

Cirrus Logic (CRUS) Beats Q4 Earnings and Revenue Estimates
Cirrus Logic (CRUS) Beats Q4 Earnings and Revenue Estimates

Cirrus Logic (CRUS) came out with quarterly earnings of $1.67 per share, beating the Zacks Consensus Estimate of $1.15 per share. This compares to earnings of $1.24 per share a year ago. These

Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates
Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates

Ultragenyx (RARE) came out with a quarterly loss of $1.57 per share versus the Zacks Consensus Estimate of a loss of $1.54. This compares to loss of $2.03 per share a year ago. These figures are

Arcutis Biotherapeutics, Inc. (ARQT) Reports Q1 Loss, Tops Revenue Estimates
Arcutis Biotherapeutics, Inc. (ARQT) Reports Q1 Loss, Tops Revenue Estimates

Arcutis Biotherapeutics, Inc. (ARQT) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.32 per share a year ago

Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates
Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates

Cytokinetics (CYTK) came out with a quarterly loss of $1.36 per share versus the Zacks Consensus Estimate of a loss of $1.41. This compares to loss of $1.33 per share a year ago. These figures are

Top Stock Picks for Week of May 5, 2025Photo, wide shot, wide-angle lens,  Telecom equipment supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/ad10ed87-71d0-4096-a50b-ba9470f8264b.png
Top Stock Picks for Week of May 5, 2025

Lam Research Corporation (LRCX) supplies wafer fabrication equipment and services to the semiconductor industry. Lam Research is riding on its strength across 3D DRAM and advanced packaging

Top Analyst Reports for Novo Nordisk, Honeywell & American Tower
Top Analyst Reports for Novo Nordisk, Honeywell & American Tower

Tuesday, May 6, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk

AI Innovator Palantir Tumbles: Time to Buy the Stock?Photo, wide shot, wide-angle lens,  Consumer electronics manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/0defe5ca-333a-451e-9549-4f262e278fc7.png
AI Innovator Palantir Tumbles: Time to Buy the Stock?

Palantir Technologies (PLTR) delivered strong Q1 2025 results, with revenue rising 39% year-over-year to $884 million and adjusted EPS meeting expectations at $0.13. The company raised its full-year

Should You Add QBTS Stock to Your Portfolio Ahead of Q1 Earnings?
Should You Add QBTS Stock to Your Portfolio Ahead of Q1 Earnings?

D-WAVE QUANTUM QBTS is set to report first-quarter 2025 results on Thursday.The Zacks Consensus Estimate for first-quarter revenues is currently pegged at $10.87 million, indicating an increase of